Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in adult Black patients with systemic lupus erythematosus
2011-005672-42Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by GSK. Started Mar 2013; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2011-005672-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005672-42.